{"pmid":32432219,"title":"Insights in Public Health: COVID-19 Special Column: The Crisis of Non-Communicable Diseases in the Pacific and the Coronavirus Disease 2019 Pandemic.","text":["Insights in Public Health: COVID-19 Special Column: The Crisis of Non-Communicable Diseases in the Pacific and the Coronavirus Disease 2019 Pandemic.","Globally, coronavirus disease 2019 (COVID-19) is threatening human health and changing the way people live. With the increasing evidence showing comorbidities of COVID-19 and non-communicable diseases (NCDs), the Pacific region, where approximately 75% of deaths are due to NCDs, is significantly vulnerable during this crisis unless urgent action is taken. Whilst enforcing the critical mitigation measures of the COVID-19 pandemic in the Pacific, it is also paramount to incorporate and strengthen NCD prevention and control measures to safeguard people with NCDs and the general population; keep people healthy and minimise the impact of COVID-19. To sustain wellbeing of health, social relationships, and the economy in the Pacific, it is a critical time for all governments, development partners and civil societies to show regional solidarity in the fight against emerging COVID-19 health crisis and existing Pacific NCDs crisis through a whole of government and whole of society approach.","Hawaii J Health Soc Welf","Tin, Si Thu Win","Vivili, Paula","Na'ati, Elisiva","Bertrand, Solene","Kubuabola, Ilisapeci","32432219"],"abstract":["Globally, coronavirus disease 2019 (COVID-19) is threatening human health and changing the way people live. With the increasing evidence showing comorbidities of COVID-19 and non-communicable diseases (NCDs), the Pacific region, where approximately 75% of deaths are due to NCDs, is significantly vulnerable during this crisis unless urgent action is taken. Whilst enforcing the critical mitigation measures of the COVID-19 pandemic in the Pacific, it is also paramount to incorporate and strengthen NCD prevention and control measures to safeguard people with NCDs and the general population; keep people healthy and minimise the impact of COVID-19. To sustain wellbeing of health, social relationships, and the economy in the Pacific, it is a critical time for all governments, development partners and civil societies to show regional solidarity in the fight against emerging COVID-19 health crisis and existing Pacific NCDs crisis through a whole of government and whole of society approach."],"journal":"Hawaii J Health Soc Welf","authors":["Tin, Si Thu Win","Vivili, Paula","Na'ati, Elisiva","Bertrand, Solene","Kubuabola, Ilisapeci"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32432219","source":"PubMed","week":"202021|May 18 - May 24","keywords":["pacific","coronavirus disease 2019","health crisis","non-communicable diseases"],"topics":["Prevention"],"weight":1,"_version_":1667342288224780290,"score":9.490897,"similar":[{"pmid":32401348,"title":"Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.","text":["Maternal health and non-communicable disease prevention: An investment case for the post COVID-19 world and need for better health economic data.","An integrated approach to population health, disease surveillance, and preventive care will dominate the health agenda in the post COVID-19 world. Because of their huge burden and the vulnerability imposed during a health crisis, prevention and care of non-communicable diseases (NCDs) will need to be prioritized even further. Maternal and child health are inextricably linked with NCDs and their risk factors. The intergenerational impact of poor maternal nutrition and health conditions during pregnancy, particularly NCD-related pregnancy complications, can be considered as a multiplier of the ongoing pandemic of NCDs. The economic cost of poor maternal health and NCD-related pregnancy complications is likely very high, but is not adequately researched or documented in the context of long-term population health. Interventions to address NCDs in pregnancy have beneficial effects on short-term pregnancy outcomes; but even more importantly, identifying \"at-risk\" mothers and offspring opens up the opportunity for targeted early preventive action. Preventive actions to address obesity, hypertension, type 2 diabetes, and cardiovascular diseases have a common lifestyle approach-identifying any one of these problems in pregnancy provides an opportunity to address them all. Cost-benefit analyses that only focus on the short-term and on one condition do not capture the full value of downstream, long-term benefits for population health. This requires urgent attention from FIGO.","Int J Gynaecol Obstet","Kapur, Anil","Hod, Moshe","32401348"],"abstract":["An integrated approach to population health, disease surveillance, and preventive care will dominate the health agenda in the post COVID-19 world. Because of their huge burden and the vulnerability imposed during a health crisis, prevention and care of non-communicable diseases (NCDs) will need to be prioritized even further. Maternal and child health are inextricably linked with NCDs and their risk factors. The intergenerational impact of poor maternal nutrition and health conditions during pregnancy, particularly NCD-related pregnancy complications, can be considered as a multiplier of the ongoing pandemic of NCDs. The economic cost of poor maternal health and NCD-related pregnancy complications is likely very high, but is not adequately researched or documented in the context of long-term population health. Interventions to address NCDs in pregnancy have beneficial effects on short-term pregnancy outcomes; but even more importantly, identifying \"at-risk\" mothers and offspring opens up the opportunity for targeted early preventive action. Preventive actions to address obesity, hypertension, type 2 diabetes, and cardiovascular diseases have a common lifestyle approach-identifying any one of these problems in pregnancy provides an opportunity to address them all. Cost-benefit analyses that only focus on the short-term and on one condition do not capture the full value of downstream, long-term benefits for population health. This requires urgent attention from FIGO."],"journal":"Int J Gynaecol Obstet","authors":["Kapur, Anil","Hod, Moshe"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32401348","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/ijgo.13198","keywords":["covid-19","health economics","health system transformation","maternal health","ncd pregnancy complications","non-communicable diseases"],"topics":["Prevention"],"weight":1,"_version_":1666714494993170432,"score":492.03848},{"pmid":32458356,"title":"The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.","text":["The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.","The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak.","Aging Clin Exp Res","Palmer, Katie","Monaco, Alessandro","Kivipelto, Miia","Onder, Graziano","Maggi, Stefania","Michel, Jean-Pierre","Prieto, Rita","Sykara, Georgia","Donde, Shaantanu","32458356"],"abstract":["The early stages of the COVID-19 pandemic have focused on containing SARS-CoV-2 infection and identifying treatment strategies. While controlling this communicable disease is of utmost importance, the long-term effect on individuals with non-communicable diseases (NCD) is significant. Although certain NCDs appear to increase the severity of COVID-19 and mortality risk, SARS-CoV-2 infection in survivors with NCDs may also affect the progression of their pre-existing clinical conditions. Infection containment measures will have substantial short- and long-term consequences; social distancing and quarantine restrictions will reduce physical activity and increase other unhealthy lifestyles, thus increasing NCD risk factors and worsening clinical symptoms. Vitamin D levels might decrease and there might be a rise in mental health disorders. Many countries have made changes to routine management of NCD patients, e.g., cancelling non-urgent outpatient visits, which will have important implications for NCD management, diagnosis of new-onset NCDs, medication adherence, and NCD progression. We may have opportunities to learn from this unprecedented crisis on how to leverage healthcare technologies and improve procedures to optimize healthcare service provision. This article discusses how the COVID-19 outbreak and related infection control measures could hit the most frail individuals, worsening the condition of NCD patients, while further jeopardizing the sustainability of the healthcare systems. We suggest ways to define an integrated strategy that could involve both public institutional entities and the private sector to safeguard frail individuals and mitigate the impact of the outbreak."],"journal":"Aging Clin Exp Res","authors":["Palmer, Katie","Monaco, Alessandro","Kivipelto, Miia","Onder, Graziano","Maggi, Stefania","Michel, Jean-Pierre","Prieto, Rita","Sykara, Georgia","Donde, Shaantanu"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458356","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s40520-020-01601-4","keywords":["covid-19","chronic diseases","coronavirus","elderly","frailty","ncd","sars-cov-2"],"e_drugs":["Vitamin D"],"topics":["Prevention"],"weight":1,"_version_":1667967698895634432,"score":483.7556},{"pmid":32393447,"title":"Non-communicable disease management in vulnerable patients during Covid-19.","text":["Non-communicable disease management in vulnerable patients during Covid-19.","It is now well established that non-communicable diseases (NCD), like diabetes mellitus, hypertension,, respiratory and heart disease, particularly among the elderly, increase the susceptibility to COVID-19 disease. Mortality in 60%-90% of the COVID-19 cases is attributed to either one or more of these comorbidities. However, healthcare management for control of COVID-19 involves public health and policy decisions that may critically undermine the existing health needs of the most vulnerable NCD patients. Temporary closure of outpatient health facilities in some secondary and tertiary care hospitals have deprived millions of NCD patients of their regular medication and diagnostic health needs. The lack of robust primary healthcare facilities in most states, and the failure to maintain physical distancing norms due to inadequate infrastructure is also problematic. In the absence of effective public health interventions, socioeconomically vulnerable patients are likely to become non-adherent increasing manifold their risk of disease complications. In this context, the feasibility of dispensing longer than usual drug refills for chronic NCD conditions at functional government health facilities, home delivery of essential drugs, running dedicated NCD clinics at PHCs, and utilisation of telemedicine opportunities for care and support to patients warrant aggressive exploration. Keywords: Covid-19, NCDs, Medical ethics, epidemic, India.","Indian J Med Ethics","Basu, Saurav","32393447"],"abstract":["It is now well established that non-communicable diseases (NCD), like diabetes mellitus, hypertension,, respiratory and heart disease, particularly among the elderly, increase the susceptibility to COVID-19 disease. Mortality in 60%-90% of the COVID-19 cases is attributed to either one or more of these comorbidities. However, healthcare management for control of COVID-19 involves public health and policy decisions that may critically undermine the existing health needs of the most vulnerable NCD patients. Temporary closure of outpatient health facilities in some secondary and tertiary care hospitals have deprived millions of NCD patients of their regular medication and diagnostic health needs. The lack of robust primary healthcare facilities in most states, and the failure to maintain physical distancing norms due to inadequate infrastructure is also problematic. In the absence of effective public health interventions, socioeconomically vulnerable patients are likely to become non-adherent increasing manifold their risk of disease complications. In this context, the feasibility of dispensing longer than usual drug refills for chronic NCD conditions at functional government health facilities, home delivery of essential drugs, running dedicated NCD clinics at PHCs, and utilisation of telemedicine opportunities for care and support to patients warrant aggressive exploration. Keywords: Covid-19, NCDs, Medical ethics, epidemic, India."],"journal":"Indian J Med Ethics","authors":["Basu, Saurav"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32393447","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.20529/IJME.2020.041","locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"topics":["Prevention"],"weight":1,"_version_":1666627828001538048,"score":438.28226},{"pmid":32295652,"pmcid":"PMC7188690","title":"Preparedness is Essential for Western Pacific Islands During the COVID-19 Pandemic.","text":["Preparedness is Essential for Western Pacific Islands During the COVID-19 Pandemic.","OBJECTIVES: To clarify the pandemic status in Western Pacific countries or territories. METHODS: The WHO's daily situation reports of COVID-19 were reviewed from January 20, 2020, to March 24, 2020. Changes in the infections, deaths, and the case fatality rate (CFR) in Western Pacific countries or territories were counted. RESULTS: As of March 24, a total of 17 countries or territories had reported the presence of COVID-19 in the Western Pacific Region, 96,580 people have been infected and a total of 3502 deaths. Fifty-three percent (9/17) of these countries or territories had their first case within 2 wk since the WHO's first report, most are China's neighbors with a large and dense population. No other country or territory in this region reported a new infection from January 30 to February 28. However, 8 (47.0%) countries or territories have reported the first cases in 3 wk since February 28, almost all are islands. Many countries maintained a small number of infections for a long time after the first report, but a rapid increase occurred later. Deaths occurred in 8 countries with a total CFR of 3.63%, and the CFR varies widely, from 0.39% (Singapore) to 7.14% (Philippines). CONCLUSIONS: The regional spread of COVID-19 urgently requires an aggressive preparedness for the Western Pacific Islands.","Disaster Med Public Health Prep","Mei, Yujie","Hu, Jijia","32295652"],"abstract":["OBJECTIVES: To clarify the pandemic status in Western Pacific countries or territories. METHODS: The WHO's daily situation reports of COVID-19 were reviewed from January 20, 2020, to March 24, 2020. Changes in the infections, deaths, and the case fatality rate (CFR) in Western Pacific countries or territories were counted. RESULTS: As of March 24, a total of 17 countries or territories had reported the presence of COVID-19 in the Western Pacific Region, 96,580 people have been infected and a total of 3502 deaths. Fifty-three percent (9/17) of these countries or territories had their first case within 2 wk since the WHO's first report, most are China's neighbors with a large and dense population. No other country or territory in this region reported a new infection from January 30 to February 28. However, 8 (47.0%) countries or territories have reported the first cases in 3 wk since February 28, almost all are islands. Many countries maintained a small number of infections for a long time after the first report, but a rapid increase occurred later. Deaths occurred in 8 countries with a total CFR of 3.63%, and the CFR varies widely, from 0.39% (Singapore) to 7.14% (Philippines). CONCLUSIONS: The regional spread of COVID-19 urgently requires an aggressive preparedness for the Western Pacific Islands."],"journal":"Disaster Med Public Health Prep","authors":["Mei, Yujie","Hu, Jijia"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295652","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1017/dmp.2020.102","keywords":["covid-19","sars-cov-2","western pacific islands"],"locations":["China","Singapore","Philippines"],"countries":["Philippines","China","Singapore"],"countries_codes":["PHL|Philippines","CHN|China","SGP|Singapore"],"topics":["Prevention"],"weight":1,"_version_":1666138493290545152,"score":294.39072},{"pmid":32314871,"title":"Targeting the Adipose Tissue in COVID-19.","text":["Targeting the Adipose Tissue in COVID-19.","The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients.","Obesity (Silver Spring)","Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca","32314871"],"abstract":["The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients."],"journal":"Obesity (Silver Spring)","authors":["Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314871","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/oby.22844","keywords":["ace2","covid-19","adipose tissue: dpp4"],"locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Treatment"],"weight":1,"_version_":1666138493464608769,"score":277.12714}]}